You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 169 No. 21, November 23, 2009 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Editorial
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Aging/ Geriatrics
 •Otolaryngology/ Head & Neck Surgery
 •Endocrine Disease of Head & Neck
 •Endocrine Diseases
 •Thyroid/ Parathyroid Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Thyrotropin Blood Levels, Subclinical Hypothyroidism, and the Elderly Patient

Joanna Klubo-Gwiezdzinska, MD; Leonard Wartofsky, MD, MACP

Arch Intern Med. 2009;169(21):1949-1951.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The term subclinical hypothyroidism (SCH) was coined by Bastenie et al1 in 1967, and the entity has remained a subject of a heated debate among clinicians ever since. There appears to be agreement on the basic definition of SCH as the finding of a thyrotropin (TSH) level above the upper limit of the reference range in the presence of normal reference range levels of serum free thyroxine (FT4) and free triiodothyronine (FT3).2 The controversy relates in part to just what is the normal reference range for TSH level, specifically the upper limit of the range beyond which a diagnosis of hypothyroidism would obtain. That upper limit has been falling in recent years from values of 6.5 or 7.0 mIU/L down to 4.1 to 4.5 mIU/L in most laboratories. We have argued that the upper limit of the reference range will be . . . [Full Text of this Article]

WHAT RISKS ARE ASSOCIATED WITH SCH?


SHOULD SCH BE TREATED?

AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Subclinical Hypothyroidism and Functional Mobility in Older Adults
Eleanor M. Simonsick, Anne B. Newman, Luigi Ferrucci, Suzanne Satterfield, Tamara B. Harris, Nicolas Rodondi, Douglas C. Bauer, and for the Health ABC Study
Arch Intern Med. 2009;169(21):2011-2017.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.